Pliant Therapeutics Inc (PLRX)
13.81
0.00 (0.00%)
USD |
NASDAQ |
May 10, 16:00
13.81
0.00 (0.00%)
After-Hours: 20:00
Pliant Therapeutics Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 1.58M |
| March 31, 2023 | 3.297M |
| December 31, 2022 | 1.983M |
| September 30, 2022 | 1.482M |
| June 30, 2022 | 4.989M |
| March 31, 2022 | 1.249M |
| December 31, 2021 | 1.998M |
| Date | Value |
|---|---|
| September 30, 2021 | 1.61M |
| June 30, 2021 | 1.83M |
| March 31, 2021 | 2.174M |
| December 31, 2020 | 9.279M |
| September 30, 2020 | 7.131M |
| June 30, 2020 | 3.599M |
| March 31, 2020 | 31.76M |
| December 31, 2019 | 7.052M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2023
31.76M
Maximum
Mar 2020
4.766M
Average
1.998M
Median
Dec 2021
Accounts Receivable (Quarterly) Benchmarks
| Masimo Corp | 330.70M |
| Liquidia Corp | 4.061M |
| Vor Biopharma Inc | -- |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -- |